Electrophoresis Market Size Incredible Possibilities and Growth Analysis

A number of factors, such as the growth in funding for research on electrophoresis techniques, increasing number of research collaborations between market players and academic institutions, increasing use of capillary electrophoresis (CE) with mass spectroscopy (MS), and growing focus on next-generation sequencing research are driving the growth of the electrophoresis market.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434

"By product, the reagents segment accounted for the largest share of the market in 2016."

On the basis of product, the reagent segment accounted for the largest share of the global electrophoresis market. This is primarily attributed to the increasing demand for 2D electrophoresis for protein separation for various applications such as biomarker discovery and protein mapping. Over the years, genomic and proteomic technologies have gained significant importance in fields of clinical diagnosis and drug discovery and development.

"By Application, the research segment held the largest market share in 2016."

Based on application, the research segment accounted for the largest share of this market. Low cost and sensitive approach for DNA sequencing, the major role of electrophoresis in drug discovery, rising use of electrophoresis techniques as a result of growing importance of antibody research in the development of biotherapeutic are the major factors driving the use of electrophoresis, which has boosted the demand for research applications.

Read More@ https://www.marketsandmarkets.com/PressReleases/electrophoresis.asp

"North America dominated the market in 2016."

Geographically, the global electrophoresis market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2016, North America held the largest share of this market, and this is primarily attributed to the growing focus of stakeholders on research projects involving proteins, associated biomolecules, and genes; stringent regulatory requirements regarding pharmaceutical manufacturing necessitating quality control and process validation processes; rising focus on the development of structure-based drug designs; and growing research activities in the fields of Genomics and proteomics.

The prominent players in the global electrophoresis market are Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.).

Bio-Rad Laboratories, Inc. (U.S.) dominated the global Electrophoresis Market in 2016. The company has a comprehensive range of electrophoresis products and consumables, and a significant global presence in the U.S. followed by Europe, Asia-Pacific, and Latin America. It offers a wide range of products in electrophoresis technologies which include nucleic electrophoresis & blotting, protein electrophoresis & blotting, power supplies, automated electrophoresis systems, gel documentation systems, and gel imaging systems.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche